Dignitana AB Cash Flow Conversion Efficiency

Latest as of March 2025: -0.115x

Dignitana AB cash flow conversion efficiency. Based on the latest financial reports, Dignitana AB (DIGN) has a cash flow conversion efficiency ratio of -0.115x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-495.00K ≈ $-53.27K USD) by net assets (Skr4.29 Million ≈ $462.10K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Dignitana AB (2008–2024)

Cash flow conversion efficiency of Dignitana AB from 2008 to 2024. This chart illustrates how Dignitana AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Dignitana AB stock price today for real-time trading data and today's change.

Dignitana AB Cash Flow Conversion Ratio Explained

Dignitana AB cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Dignitana AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Dignitana AB ranked by their cash flow conversion efficiency. Also see DIGN company net worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
KLX Energy Services Holdings Inc
NASDAQ:KLXE
-0.224x
SynCore Biotechnology Co Ltd
TWO:4192
-0.028x
Legend Mining Ltd
AU:LEG
-0.023x
AVTECH Sweden AB Series B
ST:AVT-B
0.012x
GWR Group Ltd
AU:GWR
0.020x
Southern Energy Corp
V:SOU
0.062x
Silvair Inc
WAR:SVRS
0.046x
Vulcan Infrastructure and Power Inc.
NASDAQ:VIP
0.076x

Annual Cash Flow Conversion Efficiency for Dignitana AB (2008–2024)

The table below shows the annual cash flow conversion efficiency of Dignitana AB from 2008 to 2024. Review Dignitana AB free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Skr7.11 Million
≈ $765.58K
Skr373.00K
≈ $40.14K
0.052x +106.63%
2023-12-31 Skr7.26 Million
≈ $781.72K
Skr-5.74 Million
≈ $-618.15K
-0.791x -5.57%
2022-12-31 Skr24.25 Million
≈ $2.61 Million
Skr-18.16 Million
≈ $-1.95 Million
-0.749x +46.76%
2021-12-31 Skr31.19 Million
≈ $3.36 Million
Skr-43.87 Million
≈ $-4.72 Million
-1.407x -412.70%
2020-12-31 Skr77.64 Million
≈ $8.35 Million
Skr-21.30 Million
≈ $-2.29 Million
-0.274x +44.68%
2019-12-31 Skr55.10 Million
≈ $5.93 Million
Skr-27.33 Million
≈ $-2.94 Million
-0.496x -32.15%
2018-12-31 Skr54.97 Million
≈ $5.92 Million
Skr-20.63 Million
≈ $-2.22 Million
-0.375x +42.63%
2017-12-31 Skr51.15 Million
≈ $5.50 Million
Skr-33.47 Million
≈ $-3.60 Million
-0.654x -19.45%
2016-12-31 Skr55.87 Million
≈ $6.01 Million
Skr-30.61 Million
≈ $-3.29 Million
-0.548x -4.30%
2015-12-31 Skr40.79 Million
≈ $4.39 Million
Skr-21.42 Million
≈ $-2.31 Million
-0.525x -161.33%
2014-12-31 Skr14.58 Million
≈ $1.57 Million
Skr-2.93 Million
≈ $-315.31K
-0.201x +65.34%
2013-12-31 Skr28.14 Million
≈ $3.03 Million
Skr-16.31 Million
≈ $-1.76 Million
-0.580x -33.79%
2012-12-31 Skr27.39 Million
≈ $2.95 Million
Skr-11.87 Million
≈ $-1.28 Million
-0.433x +54.53%
2011-12-31 Skr9.32 Million
≈ $1.00 Million
Skr-8.88 Million
≈ $-955.95K
-0.953x +22.45%
2010-12-31 Skr12.98 Million
≈ $1.40 Million
Skr-15.96 Million
≈ $-1.72 Million
-1.229x +36.89%
2009-12-31 Skr7.41 Million
≈ $797.86K
Skr-14.44 Million
≈ $-1.55 Million
-1.947x -589.88%
2008-12-31 Skr3.96 Million
≈ $425.84K
Skr1.57 Million
≈ $169.28K
0.398x --

About Dignitana AB

ST:DIGN Sweden Medical Devices
Market Cap
$18.55 Million
Skr172.36 Million SEK
Market Cap Rank
#25188 Global
#500 in Sweden
Share Price
Skr2.14
Change (1 day)
+0.00%
52-Week Range
Skr2.14 - Skr2.14
All Time High
Skr23.60
About

Dignitana AB (publ), a medical technology company, engages in the development, production, and marketing of medical cooling devices in the United States and internationally. It offers DigniCap, a scalp cooling system used to reduce hair loss from chemotherapy treatments, as well as for patients receiving chemotherapy to treat other solid tumors. The company was incorporated in 2007 is headquarter… Read more